Lab
Laboratory Corporation of America Holdings
Laboratory Corporation of America Holdings was paid $2.94M by Medicaid between Jan 2018 and Dec 2024, across 131 billing codes. Its largest line is 88175, Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer — 13% of everything it billed.
33Billing provider infoLABORATORY CORPORATION OF AMERICA HOLDINGS
LINCOLN, NE 68512
LINCOLN, NE 68512
33aNPI1821546680assigned 09/21/2016
33bProvider typeClinical Medical Laboratory
28Total paid$2.94M
24GClaims301,956
24DCodes billed131
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Nebraska
Rank by total paid#2 of 19
Median peer was paid$18K
This provider vs. median160×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 99,280 | $890K | |
| 2019 | 103,132 | $951K | |
| 2020 | 8,587 | $136K | |
| 2021 | 32,354 | $325K | |
| 2022 | 43,533 | $480K | |
| 2023 | 14,947 | $157K | |
| 2024incomplete | 123 | $288.66 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 13% | 23,378 | 22,555 | $377K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 11% | 13,843 | 13,150 | $319K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 11% | 13,795 | 13,109 | $318K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 8.9% | 12,512 | 12,167 | $262K |
| 80050 | General health panel | 6.1% | 6,866 | 6,594 | $181K |
| 80061 | Lipid panel | 4.5% | 18,553 | 17,886 | $134K |
| 80053 | Comprehensive metabolic panel | 4.2% | 22,931 | 21,478 | $122K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.9% | 13,640 | 13,073 | $114K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.9% | 23,888 | 21,527 | $84K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 2.9% | 5,464 | 5,295 | $84K |
| 80055 | 2.3% | 1,882 | 1,806 | $69K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2.2% | 4,232 | 4,079 | $65K |
119 more codes
| 80081 | 2.2% | 1,520 | $64K | |
| 87480 | 1.5% | 3,498 | $45K | |
| 87510 | 1.5% | 3,497 | $45K | |
| 87660 | 1.5% | 3,495 | $45K | |
| 88141 | 1.4% | 3,308 | $41K | |
| 84439 | 1.2% | 7,240 | $35K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.1% | 8,294 | $31K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,327 | $27K |
| 80074 | <1% | 1,111 | $27K | |
| 85027 | <1% | 7,042 | $25K | |
| 82607 | <1% | 3,015 | $23K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,020 | $23K |
| 36415 | Collection of venous blood by venipuncture | <1% | 19,897 | $20K |
| 86803 | <1% | 2,262 | $19K | |
| 82728 | <1% | 2,461 | $17K | |
| 83970 | <1% | 1,234 | $16K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 861 | $16K |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | <1% | 62 | $15K |
| 84702 | <1% | 1,604 | $15K | |
| 84153 | <1% | 1,321 | $14K | |
| 84403 | <1% | 780 | $12K | |
| 86787 | <1% | 1,396 | $10K | |
| 82746 | <1% | 1,339 | $10K | |
| 81001 | <1% | 5,821 | $10K | |
| 83550 | <1% | 2,209 | $10K | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 15 | $9K |
| 87625 | <1% | 377 | $9K | |
| 83540 | <1% | 2,773 | $9K | |
| 84481 | <1% | 936 | $8K | |
| 82950 | <1% | 2,102 | $7K | |
| 87186 | <1% | 1,503 | $7K | |
| 82570 | <1% | 3,011 | $7K | |
| 83001 | <1% | 562 | $6K | |
| 84146 | <1% | 508 | $6K | |
| 87088 | <1% | 1,511 | $6K | |
| 86140 | <1% | 2,070 | $6K | |
| 84144 | <1% | 420 | $6K | |
| 80069 | <1% | 1,778 | $5K | |
| 82670 | <1% | 308 | $5K | |
| 82043 | <1% | 1,894 | $5K | |
| 87077 | <1% | 1,022 | $4K | |
| 83735 | <1% | 1,421 | $4K | |
| 83690 | <1% | 1,057 | $4K | |
| 86038 | <1% | 534 | $4K | |
| 86592 | <1% | 1,379 | $3K | |
| 83516 | <1% | 188 | $3K | |
| 83880 | <1% | 303 | $3K | |
| 85652 | <1% | 1,924 | $3K | |
| 80076 | <1% | 646 | $3K | |
| 83002 | <1% | 224 | $3K | |
| 82784 | <1% | 367 | $3K | |
| 82150 | <1% | 744 | $3K | |
| 82248 | <1% | 991 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 123 | $3K |
| 84156 | <1% | 1,567 | $2K | |
| 82247 | <1% | 1,043 | $2K | |
| 86376 | <1% | 244 | $2K | |
| 85610 | <1% | 1,497 | $2K | |
| 82951 | <1% | 235 | $2K | |
| 87536 | <1% | 30 | $2K | |
| 80164 | <1% | 465 | $2K | |
| 87340 | <1% | 374 | $2K | |
| 87070 | <1% | 367 | $2K | |
| 87902 | <1% | 12 | $2K | |
| 83525 | <1% | 248 | $2K | |
| 84550 | <1% | 737 | $2K | |
| 85018 | <1% | 1,000 | $2K | |
| 82105 | <1% | 180 | $2K | |
| 81329 | <1% | 15 | $1K | |
| 84402 | <1% | 102 | $1K | |
| 84460 | <1% | 444 | $1K | |
| 82947 | <1% | 650 | $1K | |
| 84436 | <1% | 350 | $1K | |
| 84100 | <1% | 638 | $1K | |
| 82550 | <1% | 399 | $968.51 | |
| 82677 | <1% | 69 | $960.11 | |
| 86431 | <1% | 228 | $788.08 | |
| 86336 | <1% | 82 | $739.20 | |
| 87522 | Neg quan hep c or qual rna | <1% | 27 | $727.78 |
| 82977 | <1% | 205 | $721.37 | |
| 86361 | <1% | 31 | $665.61 | |
| 88142 | <1% | 57 | $620.23 | |
| 84681 | <1% | 51 | $611.22 | |
| 84703 | <1% | 112 | $533.31 | |
| 82952 | <1% | 215 | $523.55 | |
| 86696 | <1% | 51 | $521.29 | |
| 81243 | <1% | 15 | $470.48 | |
| 82565 | <1% | 361 | $448.71 | |
| 86706 | <1% | 58 | $447.86 | |
| 86695 | <1% | 51 | $399.76 | |
| 84450 | <1% | 258 | $388.17 | |
| 99199 | Unlisted special service, procedure or report | <1% | 19 | $346.80 |
| 82390 | <1% | 41 | $340.02 | |
| 80051 | <1% | 97 | $327.62 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 538 | $327.50 |
| 80178 | <1% | 102 | $301.06 | |
| 84155 | <1% | 396 | $291.44 | |
| 84480 | <1% | 32 | $274.88 | |
| 86800 | <1% | 24 | $204.77 | |
| 82040 | <1% | 231 | $187.96 | |
| 84479 | <1% | 43 | $186.02 | |
| 84165 | <1% | 54 | $154.21 | |
| 83615 | <1% | 73 | $153.57 | |
| 86762 | <1% | 26 | $138.56 | |
| 84520 | <1% | 117 | $134.02 | |
| 84163 | <1% | 15 | $133.80 | |
| 84075 | <1% | 177 | $133.40 | |
| 86777 | <1% | 15 | $121.19 | |
| 84466 | <1% | 13 | $103.35 | |
| 84206 | <1% | 12 | $100.04 | |
| 82310 | <1% | 112 | $97.80 | |
| 82533 | <1% | 15 | $79.92 | |
| 86850 | <1% | 14 | $79.91 | |
| 84132 | <1% | 81 | $77.21 | |
| 86765 | <1% | 12 | $76.87 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 38 | $74.36 |
| 84295 | <1% | 34 | $29.55 | |
| 82435 | <1% | 27 | $17.19 | |
| S3600 | Stat laboratory request (situations other than s3601) | <1% | 841 | $4.60 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILLIAMS, KIMBERLY (VICE PRESIDENT)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.